Cure8 research brief
People with IBD-like or coeliac-like bowel changes that don’t respond to usual treatments, or whose biopsies show multiple different patterns, might actually have an underlying immune disorder — recognising this can change workup and management and may explain malabsorption or protein loss.
Clinicians (gastroenterologists, immunologists, pathologists), researchers studying enteropathy and immune disorders, and adult patients with atypical or treatment-refractory IBD/coeliac-like disease.
This study reports a multicentre audit (AT-SEA) describing enteropathy in people with inborn errors of immunity (IEI). The authors reviewed 28 patients and 48 intestinal biopsy reports and found that most patients had moderate–severe disease with frequent malabsorption and protein-losing enteropathy.
Histology commonly showed overlapping patterns (coeliac-like villous atrophy and increased intraepithelial lymphocytes; IBD-like inflammation; reduced/absent plasma cells; GVHD-like apoptosis or intraepithelial neutrophilia), and most patients had two or more patterns in the same patient.
The paper’s main practical point is that IEI-associated enteropathy often shows mixed, evolving histological features rather than a single diagnostic pattern; the coexistence of multiple histological patterns was associated with more severe disease and should raise suspicion for an underlying immune defect.
If you are a patient or clinician encountering intestinal biopsies that don’t fit a single clear diagnosis (for example coeliac disease or classic IBD) or that have multiple overlapping features, this study suggests considering evaluation for an inborn error of immunity and involving immunology expertise.
Keep the focus on the source: this brief is grounded in the article abstract and multicentre audit reported by the AT-SEA working group and does not represent a systematic review of all literature.
This article is a multicentre observational audit (abstract-level content provided). It describes a small cohort (28 patients) and reports associations between histological complexity and clinician-assessed severity; it does not establish causation or provide treatment outcomes. Further larger studies are needed to define diagnostic criteria and best management pathways.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Distinguishing IBD from gastrointestinal tuberculosis is challenging in regions where GITB is common; histologic markers like basal plasmacytosis and eosinophilia on mucosal biopsy could help guide diagnosis when...
GI infections—especially CMV—were common in this study and much more frequent in acute severe UC than in remission, suggesting testing for infections can change diagnosis and management during severe flares.
CMV reactivation can worsen outcomes in active UC and influence treatment choices; clinicians and patients may benefit from additional, easy-to-measure markers that flag higher risk of tissue CMV and prompt targeted...
